Global X SuperDividend ETF vs Health Care Select Sector SPDR Fund — how do they compare? Global X SuperDividend ETF trades at $24.57, while Health Care Select Sector SPDR Fund trades at $168.42. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Global X SuperDividend ETF nearer its low. Which is the better fit depends on your goals.
| SDIV | XLV | |
|---|---|---|
Sector | Broad Market / Factor | — |
52-Week High | $26.34 | $168.44 |
52-Week Low | $22.90 | $131.16 |
Signals from Pluang's Aura AI — not financial advice
SDIV, a US-listed ETF, trades at $24.585, down 0.26% on the day, with a bearish technical signal driven by moving averages. The fund offers a high dividend yield, with recent payouts of $0.18 per share. Technical indicators show neutral oscillators but overall selling pressure, with key support at $24 and resistance at $25.
The outlook for SDIV hinges on income-seeking demand amid market volatility, as highlighted by financial media. Risks include sensitivity to interest rates and geopolitical factors. Analyst sentiment is mixed, with some upgrades citing yield attractiveness, but the bearish technical trend warrants caution for near-term price appreciation.
XLV, the Health Care Select Sector SPDR ETF, trades at $167.93, down 0.3% on the day, with a bullish technical signal driven by moving averages. The ETF offers broad healthcare exposure with a low expense ratio of 0.08% and a trailing dividend yield of 1.6%, positioning it as a cost-effective defensive play amid market volatility. Recent news highlights strong sector inflows and defensive demand, with earnings from key holdings like UnitedHealth showing resilience despite Medicaid pressures.
The outlook for XLV is positive, supported by its defensive characteristics and institutional interest, though risks include regulatory pressures and sector-specific volatility. Investors may find value in its diversification and steady performance, but should monitor healthcare policy developments and earnings trends for sustained growth.
Trailing returns across standard periods
Latest headlines on both assets
SDIV is an ETF that invests in 100 of the highest dividend-yielding equity securities in the world. The fund seeks to provide a high level of income to investors by selecting companies from both developed and emerging markets that have historically provided high dividend yields. By diversifying globally, SDIV aims to mitigate risks associated with focusing on a single country, while offering monthly distributions to its shareholders.
Read more on SDIV →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →